4-(2-amino-6-chloro-9h-purin-9-yl)-1,3-dioxolane-2-methanol has been researched along with Neoplasm Metastasis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Acevedo-Duncan, M; Apostolatos, AH; Ostrov, DA; Ratnayake, WS | 1 |
1 other study(ies) available for 4-(2-amino-6-chloro-9h-purin-9-yl)-1,3-dioxolane-2-methanol and Neoplasm Metastasis
Article | Year |
---|---|
Two novel atypical PKC inhibitors; ACPD and DNDA effectively mitigate cell proliferation and epithelial to mesenchymal transition of metastatic melanoma while inducing apoptosis.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Dioxolanes; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Isoenzymes; Melanocytes; Melanoma; Molecular Docking Simulation; Naphthalenes; Neoplasm Metastasis; Protein Kinase C; Purines; RNA, Small Interfering; Signal Transduction; Sulfonic Acids | 2017 |